You might be surprised at the very positive resp
Post# of 72433
![Avatar](/images/ProfileImages/1448554151_3056_img874.jpg)
You might be surprised at the very positive response the investor community can have towards a phI that fulfills its safety goals Bio. The majority of the seasoned biotech community really do know that that is a big, huge deal. Most people don't expect treatment effects until later trials - when the treatment dose is established. So - I don't think there will be the sell off you imagine. Also - there are many other measures of effect that will be drawn from this trial - the biomarkers being perhaps the most important - so that future trials can be designed around the most susceptible cancers - enhancing efficacy chances even more.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)